Introduction {#s1}
============

To enable the correct and complete transfer of genetic information during cell division, DNA polymerases efficiently replicate the genome by pairing nucleotide bases opposite their complementary template base. However, despite the polymerase proofreading ability, incorrect nucleotides are occasionally incorporated into the new DNA strand, resulting in mutations when left uncorrected. To reduce the number of such mismatches and maintain genomic stability, replication is followed by DNA mismatch repair (MMR) in almost all cellular organisms ([@bib44]; [@bib37]). The initiation of this MMR system is evolutionarily conserved, although in eukaryotes heterodimeric homologs replace the bacterial homodimeric components. Defects in MMR result in a mutator phenotype and in humans in predisposition for cancer, known as Lynch syndrome or HNPCC ([@bib50]).

MMR is initiated when a MutS homolog binds to a mismatch. In this mismatch recognition step, the MutS dimer kinks the DNA at the site of the mismatch and stacks a phenylalanine onto the mispaired base ([@bib46]; [@bib61]; [@bib69]). Upon ATP binding MutS releases the mismatch ([@bib2]; [@bib74]) and travels as a 'sliding clamp' along the DNA helix ([@bib21]; [@bib1]; [@bib36]), and this specific state of MutS is recognized by MutL or its homologs ([@bib22]; [@bib64]; [@bib15]; [@bib1]).

MutL proteins are constitutive dimers through their C-terminal domains, while the N-terminal ATPase domains reorganize and dimerize upon ATP binding ([@bib22]; [@bib8]; [@bib7]; [@bib24]). Once recruited by the MutS sliding clamp, the MutL homologs activate downstream repair. This includes the nicking of the newly replicated strand by a nuclease, which is either part of the MutL C-terminal domain ([@bib41]), or a separate protein such as MutH in *Escherichia coli* ([@bib25]). MutL also activates UvrD in bacteria to unwind the DNA ([@bib73]), after which the new DNA strand can be removed and re-replicated ([@bib44]).

As loss of MutS homologs (MSH2, MSH3 and MSH6 in humans) or MutL homologs (MLH1 and PMS2 in humans) leads to mutator and/or cancer phenotypes, these proteins evidently have critical roles in mismatch repair and it is therefore important to understand their exact mechanism. Despite extensive studies ([@bib21]; [@bib55]; [@bib12]; [@bib65]), it is unclear how MutS achieves the sliding-clamp state, how this promotes MutL recognition and why this results in activation of the MutL protein.

Here, we trap the transient complex between MutS and MutL to resolve a crystal structure of the MutS sliding clamp bound to MutL. This is, to our knowledge, the first time that not only this MutS conformation but also the complex between MutS and MutL could be observed. We show how rearrangements in MutS promote interactions from both MutS subunits with a single MutL N-terminal domain, and how this domain is then positioned to load onto DNA running through a novel channel in the MutS dimer. We use biophysical methods to analyze the transient states and mechanistically understand the specificity and effect of MutL binding to MutS, and functional assays to address how this affects MMR initiation.

Results {#s2}
=======

Structure of the MutS/MutL complex {#s2-1}
----------------------------------

To trap the *E. coli* MutS/MutL complex we used site-specific chemical crosslinking of single-cysteine variants of MutS and MutL, with a flexible BM(PEO)~3~ crosslinker. First all cysteines in MutS and MutL were replaced and functionality of the resulting protein was confirmed ([@bib18]; [@bib51]; [@bib71]). Then single cysteines were introduced to find positions where crosslinking was dependent on sliding clamp formation. MutS D246C crosslinks specifically to MutL N131C only when a DNA mismatch and a nucleotide are present ([@bib71]; [Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), indicating that a complex relevant for MMR is trapped.10.7554/eLife.06744.003Figure 1.Crystal structure of the crosslinked MutS^ΔC800^/MutL^LN40^ complex.(**A**) DNA and ATP-dependent crosslinking of MutS^ΔC800^ D246C (S) and MutL^LN40^ N131C (L) and large-scale purification. Constructs and domain definitions are shown. (**B**) Crystal structure of the trapped transient complex of MutS^ΔC800^ dimer (blue/cyan) with MutL^LN40^ (green). (**C**) Comparison between MutS^ΔC800^ in mismatch-recognition state (1E3M.pdb) and the MutS^ΔC800^/MutL^LN40^ complex, with MutS subunit B colored as in (**A**). (**D**) The dimer subunits (blue/cyan) tilt across each other (connector and mismatch-binding domains not shown for clarity) compared to the mismatch-bound state (red/pink). (**E**) The connector domain (blue/cyan) rotates around residues 265--266 compared to the mismatch-bound state (red/pink) relative to other domains. Reorientation of residues 128 and 246 indicated. (**F**) Each MutL^LN40^ subunit (green) interacts via two interfaces (orange/yellow) with the MutS^ΔC800^ dimer (blue/cyan).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.003](10.7554/eLife.06744.003)10.7554/eLife.06744.004Figure 1---figure supplement 1.Crosslinking, purification and crystal structure of the 856 MutS^ΔC800^/MutL^LN40^ complex.(**A**) Single-cysteine MutS D246C and single-cysteine MutL 857 N131C constructs with replaced and introduced cysteine positions are shown, and colored 858 according to domain definitions in main text Figure 1. (**B**) Final size-exclusion 859 chromatography profile and corresponding SDS-PAGE gel for the purification of the 860 MutS^ΔC800^/MutL^LN40^ complex (SL). Pooled fractions are indicated. (**C**) Two rounds of 861 crosslinking and purification of MutS^ΔC800^ D246C and MutL^LN40^ N131C result in almost all 35 MutS^ΔC800^ subunits crosslinked to MutL^LN40^, as shown on SDS-PAGE (862 elutions from Talon 863 beads and size-exclusion chromatography \[SEC\] are indicated).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.004](10.7554/eLife.06744.004)10.7554/eLife.06744.005Figure 1---figure supplement 2.Electron density for different crystal forms of the MutS^ΔC800^/MutL^LN40^ complex.Electron density shown in region around the domain indicated at contour level 1.0 rmsd and 3.50 rmsd for the difference density map. (**A**) Crystal form 1, (**B**) Crystal form 2, (**C**) Crystal form 3.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.005](10.7554/eLife.06744.005)

For structural studies, we scaled up the reaction and removed C-terminal domains from MutS and MutL ([Figure 1A](#fig1){ref-type="fig"}), to capture the complex between MutS^ΔC800^ D246C (which we will refer to as MutS^ΔC800^) and the 40 kDa N-terminal LN40 domain ([@bib8]) of MutL N131C (which we will refer to as MutL^LN40^). The proteins were crosslinked in the presence of mismatched DNA and ATP, followed by purification to obtain the protein, and then this cycle was repeated in order to obtain fully crosslinked material. This generated a complex where each MutS^ΔC800^ subunit in the dimer binds to a MutL^LN40^ monomer ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1B,C](#fig1s1){ref-type="fig"}), which was sufficiently homogeneous and stable to allow crystallization.

We crystallized the MutS^ΔC800^/MutL^LN40^ complex in the presence of DNA containing a G:T mismatch and the non-hydrolyzable ATP analog AMP-PNP (adenylyl-imidodiphosphate). The complex crystallized in several different space groups, diffracting to resolutions from 7.6 to 4.7 Å. In all crystal forms, we could elucidate the same structure of the protein complex ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}), using parts of higher-resolution MutS^ΔC800^ and MutL^LN40^ structures for molecular replacement.10.7554/eLife.06744.019Table 1.Data collection and refinement statistics**DOI:** [http://dx.doi.org/10.7554/eLife.06744.019](10.7554/eLife.06744.019)Crystal form 1 27-bp DNACrystal form 2 27-bp DNACrystal form 3 100-bp DNAData collection Space groupC2C2P2~1~ Cell dimensions  *a*, *b*, *c* (Å)165.9, 188.5, 200.4380.6, 126.5, 243.3192.6, 109.4, 277.5  *α*, β, γ (°)90.0, 94.8, 90.090.0, 91.4, 90.090.0, 90.0, 90.0 Resolution (Å)[\*](#tblfn1){ref-type="table-fn"}82.7--4.71 (4.96--4.71)49.94--6.6 (7.13--6.6)49.3--7.6 (8.5--7.6) *R*~merge~19.4 (79.7)21.3 (80.1)16.8 (91.9) *I*/σ*I*2.5 (1.0)3.4 (1.1)4.3 (1.0) Completeness (%)97.3 (98.0)96.8 (97.7)81.3 (82.5) Redundancy2.4 (2.4)2.9 (3.0)2.3 (2.2)Refinement Resolution (Å)4.76.67.6 No. reflections31,05221,30511,763 *R*~work/~ *R*~free~31.8/35.025.6/28.726.2/30.5 No. atoms21,90645,05445,054  Protein21,81344,86844,868  Ligand/ion93186186  Water000 B-factors  Protein212255221  Ligand/ion220212171  Water*n/an/an/a* R.m.s deviations  Bond lengths (Å)0.0090.01030.0113  r.m.s. Z (bonds)0.450.510.55  Bond angles (°)1.321.351.31  r.m.s. Z (angles)0.590.700.68[^1]

The crystal structure shows a novel conformation of MutS, in which the subunits in the dimer are tilted across each other by ∼30°, compared to the mismatch recognition state ([Figure 1C,D](#fig1){ref-type="fig"}). The subunits are tilted as a rigid body, but the C-terminal HTH domains hinging around residues 765--766, move with the opposite subunit, maintaining their role in stabilizing MutS dimers ([@bib10]). Meanwhile, the connector domains are rotated by ∼160° around a hinge at residues 265--266, which moves these domains out of the center of the molecule and packs them against the ATPase domains ([Figure 1C,E](#fig1){ref-type="fig"}). The mismatch-binding domain could not be resolved in the density, probably because it is flexible in this state. While the mismatch recognition state of MutS is asymmetric ([@bib46]), this MutL^LN40^-bound conformation shows a more symmetrical MutS^ΔC800^ dimer.

The MutL^LN40^ interaction with MutS^ΔC800^ involves two interfaces ([Figure 1F](#fig1){ref-type="fig"}). The first interface is formed by the largest β-sheet of the ATPase domain of MutL^LN40^, and the ATPase and core domains of one subunit of MutS^ΔC800^. The second interface involves the side of this same β-sheet and a looped-out helix of MutL^LN40^, and the newly positioned connector domain of the other MutS^ΔC800^ subunit. Each MutL^LN40^ monomer is therefore interacting with both subunits in the MutS^ΔC800^ dimer.

Conformation of the MutS sliding clamp {#s2-2}
--------------------------------------

The novel conformation of MutS in our crystal structure reveals a rearrangement of the subunits in the MutS^ΔC800^ dimer, tilting around the interface formed by the two ATPase sites ([Figure 1D](#fig1){ref-type="fig"}, [Video 1](#video1){ref-type="other"}). The tilting creates a new MutS dimer interface of ∼500 Å^2^ where the clamp domains cross over, partially from interactions between the helices themselves (200 Å^2^), the rest from the ends of the clamp domains with the helices.Video 1.Interpolation between two MutS conformations.Interpolation between the mismatch-bound conformation of MutS and the conformation as observed in complex with MutL^LN40^ shows tilting of the MutS subunits across each other. The connector domain rotates outward, although the exact trajectory may be different than in this visualization. Mismatch-recognition domains are not shown since they are not visible in the MutS^ΔC800^/MutL^LN40^ structure.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.009](10.7554/eLife.06744.009)10.7554/eLife.06744.009

We observe nucleotide density in the ATP binding sites of both subunits in the MutS^ΔC800^ dimer ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), and since we crystallized the protein with AMP-PNP we modeled these nucleotides in the density. This type of ATP-induced tilting and increased packing of ATPase domains is more often observed upon ATP binding in ABC ATPases, such as ATP transporters, SMCs and RAD50 ([@bib32]). Based on comparison to RAD50 ([@bib31]) we previously predicted a tilting motion ([@bib45]), and an open-to-closed transition has been supported by deuterium exchange mass spectrometry ([@bib56]), but the crossing of the clamp domains of MutS and the effect that this has on DNA binding were unexpected.

The type of rearrangement of the MutS N-terminal region was similarly unexpected. In this movement the connector domains have rotated onto the so-called 'signature helix' (residues 670--684) ([@bib32]), whose amino terminus interacts with the γ-phosphate of the ATP in the opposite subunit in ABC ATPases. Therefore the observed connector domain movement could be the result of binding of ATP in the opposing subunit.

In RAD50 this tilting or 'closing' motion is transmitted through a 'signature coupling helix' via charged interactions with the signature helix ([@bib70]; [@bib14]). This 'coupling helix' is found at the beginning of a long stretch (144--767) in RAD50 that includes the coiled coil region and ends in the signature helix. The equivalent region in MutS is only 10 residues long (660--669) and it is disordered in all structures. It is feasible that this 10-residue loop is critical for transmission of the ATP signal, but the details must be different, since the basic residues in the signature helix of RAD50 are not conserved in MutS.

To validate the relevance of the observed conformational changes for the MMR process, MutS proteins with a single cysteine at position 449 were site-specifically labeled with two different Alexa fluorophores and combined into heterodimers by random subunit exchange ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). When labeled protein was bound to end-blocked DNA containing a G:T mismatch, FRET increased upon ATP addition. This indicates that ATP-induced sliding clamp formation moves these residues toward each other, in line with the shorter distance in the new conformation (from 50 Å in the mismatch-recognition state to 43 Å in the MutL^LN40^-bound structure).10.7554/eLife.06744.006Figure 2.The structure of the MutS^ΔC800^/MutL^LN40^ complex reveals the MutS sliding clamp conformation.(**A**) FRET within MutS dimers (normalized for unbound protein) reveals residues 449 coming closer together upon ATP addition. Error bars depict mean ± SD, n = 3. (**B**) FRET assay agrees with residue 246 on the connector domain of MutS moving towards residue 798 upon ATP addition after mismatch recognition. (**C**) Mismatch and ATP-induced conformational changes open a channel lined by positively charged residues (left: arginines and lysines as red sticks, middle: electrostatic surface), which would fit a DNA helix (right). (**D**) FRET assay agrees with movement of DNA away from residues 449 in MutS, while approaching residues 336 upon ATP addition as schematically depicted (DNA mismatch represented by pink star).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.006](10.7554/eLife.06744.006)10.7554/eLife.06744.007Figure 2---figure supplement 1.ATP-analog and DNA in the crystal structure.(**A**) Difference density map for AMP-PNP (mFo-DFc at 2.8σ) after refinement without the nucleotide is shown for MutS subunit A in the 4.7 Å crystal structure. (**B**) The asymmetric unit in the P2~1~ crystal form that diffracted to 7.6 Å, which was crystallized with 100-bp DNA aligns the channels in the three MutS^ΔC800^ dimers (green, violet and pink cartoon representations) such that a DNA strand would fit through all complexes simultaneously. (**C**) Sequence conservation of the positively charged residues (indicated by asterisks) in the DNA channel of the MutS sliding clamp. Red: positive charge fully conserved; orange: conserved in \>50% of the species shown; yellow: conserved in \<50% of the species shown. (**D**) No change in FRET between labeled residue 246 on MutS and labeled DNA is observed upon addition of ATP, in agreement with reorientation of the connector domain concomitant with repositioning of the DNA to the new channel.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.007](10.7554/eLife.06744.007)10.7554/eLife.06744.008Figure 2---figure supplement 2.FRET assay -- controls and raw data.(**A**) FRET (normalized for unbound protein) within MutS D835R heterodimers (449-AF488/449-AF594) reveals residues 449 coming closer together upon ATP addition when bound to mismatch DNA. Bars depict mean +/− SD, n = 3. (**B**) FRET assay within MutS D835R heterodimers (246-AF594/798-AF488) shows that residue 246 on the connector domain of MutS moving towards residue 798 upon ATP addition when bound to mismatch DNA. Bars depict mean +/− SD, n = 3 (**C**) Example of emission spectra with excitation at 485 nm (solid lines) or 590 nm (dashed lines) of MutS D835R heterodimers (449-AF488/449-AF594 (left) or 246-AF594/798-AF488) (right) (in the presence of the indicated DNA (GT-59 or homoduplex DNA λ-DNA) in the absence (black) or presence of ATP (red). (**D**) Example of emission spectra with excitation at 435 nm (solid lines) or 590 nm (dashed lines) of MutS D835R variants 246 (top) that corresponds to bar graph in [Figure 2---supplement 1D](#fig2s1){ref-type="fig"}, 336 (middle) or 449 (bottom) that correspond to bar graph in [Figure 2D](#fig2){ref-type="fig"}. The proteins labeled with Alexa Fluor 594 in the presence of the indicated DNA (GT30 or AT30) stained with Sytox Blue in the absence (black) or presence of ATP (red). (see Materials and Methods for details).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.008](10.7554/eLife.06744.008)

The new position of the connector domain brings it closer to the ATPase domain ([Figure 1E](#fig1){ref-type="fig"}, [Video 1](#video1){ref-type="other"}). To analyze this movement we combined two single-cysteine variants of MutS, labeled in the connector domain (residue 246) and the ATPase domain (residue 798) respectively, into heterodimers, and measured the FRET signal between these sites upon sliding clamp formation ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Indeed, after ATP addition the FRET increased, indicating that these residues come closer together. As this is measured in the absence of MutL it suggests that after mismatch binding, ATP is sufficient to induce movement of the connector domain away from the mismatch-recognition position.

Although the complex was crystallized in the presence of DNA containing a mismatch, the DNA is not visible in the structure. This could be due to smearing out of the electron density over multiple positions or the DNA may not be present in the crystal, both indicating that the mismatch has been released, as expected for the ATP-bound state of MutS.

The subunit tilting has occluded the original DNA binding site, but because the connector and mismatch-binding domains have moved, a large channel (∼35 Å wide) in MutS has become accessible, which could easily accommodate a DNA duplex (20 Å diameter). The new channel is lined by conserved lysines and arginines ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), which can govern nonspecific contacts with the negative backbone of DNA, as expected for the MutS sliding clamp state ([@bib12]). Moreover, in our crystal forms these channels are aligned between symmetry mates or even within the asymmetric unit ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). This packing of MutS/MutL complexes is most likely a crystallographic artefact, as it could not occur in the presence of MutL dimers, but the alignment could reflect the path of the DNA present during crystallization. We hypothesize that the DNA is pushed down to this channel during the ATP-induced conformational changes of MutS after mismatch recognition.

To test whether DNA moves down into the new channel in solution, we analyzed FRET signals between fluorescently labeled DNA (end-blocked) and specific sites in single-cysteine MutS variants ([Figure 2D](#fig2){ref-type="fig"}). After addition of ATP, DNA moves away from residues 449 at the DNA-clamp position (FRET/acceptor ratio reduction ∼1.5 fold), while an increase in FRET/acceptor ratio (\>3.6 fold) was observed when MutS was labeled at position 336. Since the connector domain moves down itself, no substantial change in FRET/acceptor ratio is observed between residue 246 and DNA ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Combined, these FRET data are in agreement with repositioning of the DNA towards the channel created by the new conformation.

Based on these validations, we conclude that the observed MutS conformation in our crystal structure is induced by ATP after mismatch recognition. Since the new position of the DNA would allow MutS to fit as a loose ring around the DNA duplex (with a channel size similar to that of PCNA ([@bib43])), consistent with free movement over DNA ([@bib12]), we propose that this is the MutS sliding clamp conformation.

Orientation of MutL^LN40^ on MutS {#s2-3}
---------------------------------

In the structure MutL^LN40^ makes two interfaces with MutS^ΔC800^. Interface 1 orients MutL^LN40^ on the ATPase and core domains of MutS. Recently, a loop in *Bacillus subtilis* MutS was found to be essential for MutL interaction ([@bib49]). Although the equivalent loop is shorter in *E. coli* MutS and the explicit residues (F319/F320) are missing, the corresponding region is located within the ∼590 Å^2^ interface (interface 1) with MutL^LN40^.

We validated the observed interaction at interface 1 by a crosslinking experiment with a short crosslinker. We created single-cysteine mutants MutS^ΔC800^ A336C and MutL^LN40^ T218C ([Figure 3A](#fig3){ref-type="fig"}), which are located ∼7.4 Å apart in the structure, and then showed that we could crosslink them efficiently with a short cysteine-specific crosslinker (8 Å, BMOE), dependent on the presence of both mismatched DNA and ATP ([@bib71]). Only background crosslinking occurred when using MutS^ΔC800^ D246C (connector domain) with MutL^LN40^ T218C (interface 1) under these conditions ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), indicating that the crosslinking between MutS^ΔC800^ A336C and MutL^LN40^ T218C is specific.10.7554/eLife.06744.010Figure 3.Interaction of the MutS^ΔC800^ sliding clamp with MutL^LN40^.(**A**) Crosslinking occurs between MutS^ΔC800^ A336C and MutL^LN40^ T218C using BMOE (right panel), as suggested by the structure (left panel). (**B**) Spontaneous mutation rates after complementing MutS or MutL-deficient cells with the indicated mutants. Error bars represent 95% confidence intervals. (**C**) SPR assay to measure MutL binding to pre-formed MutS sliding clamps on end-blocked DNA. MutL contribution (green dotted line) is approached by subtracting MutS-only contribution (blue line) from the total signal (solid line). Data normalized to maximum MutS response. (**D**) MutL and MutS mutants with deficiency in MMR show reduced MutS/MutL complex formation in SPR. Error bars represent SD for averages between two experiments. (**E**) The yellow patch of MutS^ΔC800^ interacts with MutL^LN40^ in the new conformation after rearrangement of the connector domain. (**F**) Residues in MutS^ΔC800^/MutL^LN40^ interfaces. Red: full MMR deficiency upon mutation; orange: deficiency upon combination; white: mild effect.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.010](10.7554/eLife.06744.010)10.7554/eLife.06744.011Figure 3---figure supplement 1.MutS--MutL interaction.(**A**) MutS^ΔC800^ D246C and MutL^LN40^ T218C do not crosslink efficiently with either a short (BMOE, 8 Å) or a long (BM\[PEO\]~3~, 18 Å) crosslinker, as e.g. seen by lack of MutS and MutL depletion. (**B**) MutS P595A/I597A/M759D shows ATPase activity with similar *K*~m~ (9.5 ± 1 μM) as WT MutS (8.1 ± 0.7 μM) but differs in *K*~cat~ (mutant: 3.8 ± 0.1 min^−1^; WT 8.3 ± 0.2 min^−1^). Data points are averages between two measurements and error bars indicate standard deviations. (**C**) MutS P595A/I597A/M759D shows similar sliding clamp formation as WT MutS (assay on end-blocked 21-bp DNA with dT~20~ linker; [@bib23]). (**D**) Without preformed MutS sliding clamps, there is only little binding of MutL to DNA. (**E**) The region in the ATPase domain that is solvent exposed during mismatch recognition but showed reduced deuterium exchange upon MutL binding (red, residues 673--686) (Mendillo et al., 2009) is buried by the connector domain (light blue surface; orange patch is close to residues 673--686). (**F**) The association with the MutS^ΔC800^ sliding clamp (blue/cyan) does not sterically hinder potential dimerization by the MutL^LN40^ domains (dimer modeled in green and grey as present in pdb entry 1NHJ).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.011](10.7554/eLife.06744.011)10.7554/eLife.06744.012Figure 3---figure supplement 2.(**A**) MutL^LN40^ (L) coelutes with crosslinked MutS^ΔC800^/MutL^LN40^ complex (SL) from size-exclusion chromatography (right), after incubation with 100-bp DNA with a G:T mismatch and AMP-PNP, indicating that MutL can still dimerize in this complex.(B) Model for MSH2/MSH6 interaction with MLH1/PMS2, in which the N-terminus of MLH1 simultaneously binds to the connector domain of MSH2 and the APTase and core domains of MSH6.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.012](10.7554/eLife.06744.012)

To further verify interface 1 between MutS and MutL, we tested whether mutations in the interface affected MMR activity in vivo, in a complementation assay with MutS or MutL deficient cells ([Figure 3B,F](#fig3){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}). We found several mutants of MutL (A138E, A138E/H139A, R55D/R57D, or combinations) and a triple mutant in MutS (P595A/I597A/M759D) that could not complement loss of wild type (WT) protein. We purified the mutants that impaired MMR and characterized their defects. The MutS triple mutant has a slight defect in ATPase activity but this does not impair its sliding clamp formation ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}), and other mutants with similar ATPase effects (e.g. MutS F596A) can almost fully reconstitute MMR ([@bib39]), suggesting that the in vivo effect we observe is due to the perturbed interface with MutL.10.7554/eLife.06744.013Table 2.Mutation rates for MutS and MutL mutants as determined using in vivo complementation assays**DOI:** [http://dx.doi.org/10.7554/eLife.06744.013](10.7554/eLife.06744.013)ProteinMutations per 10^7^(95% confidence interval)MutS variant (MutL interface) *Empty vector*0.601(0.446--0.772) *WT MutS*0.0686(0.0408--0.101) *MutS P595A/I597A*0.0545(0.0310--0.0826) *MutS M759D*0.0819(0.0490--0.121) *MutS Y563A*0.0488(0.0272--0.0749) *MutS P595A/I597A/M759D*0.704(0.556--0.864) *MutS Y563A/P595A/I597A*0.317(0.233--0.411) *MutS Y563A/P595A/I597A/M759D*0.773(0.618--0.941)MutL variant (MutS interface) *Empty vector*5.43(4.00--7.00) *WT His-MutL*0.121(0.0542--0.206) *His-MutL A138E*2.76(2.12--3.46) *His-MutL H139A*0.103(0.0439--0.179) *His-MutL A138E/H139A*4.87(3.55--6.33) *His-MutL R55D/R57D*6.41(4.99--7.95) *His-MutL R200D*0.663(0.432--0.932) *His-MutL R55D/R57D/H139A*5.33(3.93--6.89) *His-MutL R55D/R57D/A138E/H139A*6.13(4.58--7.84) *His-MutL R55D/R57D/H139A/R200D*5.22(3.84--6.76) *His-MutL R55D/R57D/A138E/H139A/R200D*5.48(4.04--7.06)MutL variant (DNA binding) *His-MutL R266E*5.87(4.78--7.04) *His-MutL R162E/R266E/R316E*5.39(4.37--6.49)[^2]

To assess the effect of these mutations on binding of MutL to the transient MutS sliding clamp we designed a two-stage assay using Surface Plasmon Resonance (SPR). We first formed and trapped MutS sliding clamps on 100-bp end-blocked DNA in the presence of ATP ([@bib23]). Next, MutL was injected, which could then bind to these MutS clamps. By subtraction of the MutS signal, the contribution of MutL could be evaluated for the different mutants ([Figure 3C](#fig3){ref-type="fig"}), since MutL alone shows no DNA binding under these conditions ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Indeed the interface 1 mutants that were deficient for MMR conferred a deficiency in MutS/MutL complex formation ([Figure 3D](#fig3){ref-type="fig"}).

MutS sliding clamp recognition by MutL {#s2-4}
--------------------------------------

The rearrangement of the connector domain creates a second interface with MutL^LN40^ (interface 2, [Figure 3E](#fig3){ref-type="fig"}). Previous deuterium exchange experiments ([@bib54]) indicated that the connector domain interacts with MutL, particularly via MutS glutamines 211 and 212. Indeed in our structure these residues are buried within this ∼670 Å^2^ interface with MutL^LN40^ ([Figure 3F](#fig3){ref-type="fig"}). Interestingly, the deuterium exchange experiments identified a second region on the MutS surface that was protected upon MutL interaction in the ATPase domain (residues 673--686). These residues are located in the 'signature helix' of MutS ([@bib32]) and in the complex structure this region is masked by the MutS^ΔC800^ connector domain in its new position ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}).

ATP binding is sufficient to displace the connector domain ([Figure 2B](#fig2){ref-type="fig"}), and MutL^LN40^ interaction may stabilize the position of the connector domain that we see in the crystal structure. At the resolution of our structure, there is no clear electron density for the connecting crosslinker that we used to stabilize the complex, and the crosslinked residue 131C on MutL^LN40^ could not be modeled. However, the distance between Cα atoms of crosslinked residue 246C in MutS^ΔC800^ and residue 132 in MutL^LN40^ is shorter (∼15.5 Å) than the 18 Å crosslinker (further spaced by cysteine side-chains), showing that the crosslinker can not enforce the observed position of the connector domain.

On the MutL side of interface 2, residue K52 of MutL^LN40^ is involved in the interaction with the connector domain of MutS^ΔC800^ ([Figure 3F](#fig3){ref-type="fig"}). This explains the previously reported unexpected mutator phenotype of MutL K52C ([@bib18]). To confirm its role in the interface we measured the binding of MutL K52C to the MutS sliding clamp in our SPR assay ([Figure 3D](#fig3){ref-type="fig"}). Indeed, the binding of this mutant is reduced compared to WT MutL.

The ATP-induced tilting of the subunits within MutS and the accompanying connector domain movement positions interfaces 1 and 2 such that they become simultaneously available for binding to the N-terminal domain of MutL ([Figure 1F](#fig1){ref-type="fig"}). Perturbing either interface 1 or interface 2 impairs MutL binding and MMR ([Figure 3F](#fig3){ref-type="fig"}). This explains the specificity of MutL for the MutS sliding clamp, which has never been understood before.

MutL proteins dimerize through the C-terminal LC20 domains. The LN40 domains are monomeric in isolation, but can form unstable dimers after ADP or ATP binding or stable dimers when incubated with AMP-PNP ([@bib8]; [@bib7]). Our crosslinked protein crystallizes as MutS^ΔC800^ dimers bound to MutL^LN40^ monomers, and does not show the MutL^LN40^ dimer arrangement through crystal contacts. Accordingly the MutL monomers have the apo-conformation of residues 80--103 ([@bib8]) and no density for a nucleotide is visible. However, the interfaces with MutS sterically allow MutL dimerization ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}), and in analytical gel filtration, MutL^LN40^ coelutes with the S~2~/L~2~ complex after incubation with DNA and AMP-PNP ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}).

The stoichiometry of the MutS/MutL complex in vivo is a topic of interest ([@bib30]; [@bib16]). To obtain crystallizable complexes, MutL^LN40^ was bound to each MutS^ΔC800^ subunit in our experiments, but during MMR a symmetric complex may not be necessary. Indeed the asymmetry of the eukaryotic MMR proteins suggest that this is not required and that a single heterodimeric MutLα will bind to one MSH2/MSH6 or MSH2/MSH3 heterodimer. Literature suggests that interface 2 will be made with MSH2 ([@bib54]), implying that interface 1 will be with MSH6. The observed MutL^LN40^ protein would then correlate with the MLH1 subunit ([@bib62]) ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}).

Binding to MutS positions MutL on DNA {#s2-5}
-------------------------------------

MutL and homologs have weak DNA binding ability ([@bib9]; [@bib7]; [@bib26]; [@bib62]) which is only clearly observed in low salt conditions, and retention of MutS on DNA upon MutL interaction has been observed ([@bib15]; [@bib67]). Although different from the proposed DNA orientation in the crystal ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), a model can be constructed in which the DNA running through the channel in the MutS sliding clamp is simultaneously bound by the proposed DNA binding grooves of the MutL^LN40^ subunits ([@bib68]) ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). While such DNA binding may require additional conformational changes of MutL, it suggests a mechanism where MutS loads MutL onto DNA.10.7554/eLife.06744.014Figure 4.The MutS sliding clamp positions MutL onto DNA.(**A**) Model of DNA binding by the MutS^ΔC800^/MutL^LN40^ complex. Three arginines in the MutL^LN40^ DNA-binding groove are shown as red spheres. (**B**) In the presence of ATP, MutS^ΔC800^ has a fast off-rate from 100-bp DNA and MutL^LN40^ alone does not bind DNA under physiological salt (150 mM KCl), while the crosslinked MutS^ΔC800^/MutL^LN40^ complex releases slowly from DNA. (**C**,**D**) Mutations in the DNA-binding groove of MutL reduce its DNA-binding ability (observed in low salt, 50 mM KCl) (**C**) and affect release rates of the MutS^ΔC800^/MutL^LN40^ complex in physiological salt conditions (**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.014](10.7554/eLife.06744.014)10.7554/eLife.06744.015Figure 4---figure supplement 1.DNA binding by the MutS^ΔC800^/MutL^LN40^ complex.(**A**) The model for MutS^ΔC800^/MutL^LN40^ complex on DNA (orange) sterically allows for LN40 dimerization (dimer modeled in green and grey as present in pdb entry 1NHJ). (**B**) Analysis as in [Figure 4B](#fig4){ref-type="fig"}, but using shorter, 41-bp mismatched DNA (ATAGGACGCTGACACTGGTGC[T]{.ul}TGGCAGCTTCTAATTCGAT annealed with ATCGAATTAGAAGCTGCCA[G]{.ul}GCACCAGTGTCAGCGTCCTAT) shows that crosslinked LN40 slows down the MutS sliding clamp on with a G:T mismatch, but point mutations in the MutL^LN40^ DNA-binding groove can abolish this. (**C**) Absolute response from the assay on 41-bp DNA fitted (single-site binding mode) to estimate maximum signal. Comparison shows that maximum response for MutS^ΔC800^/MutL^LN40^ binding (150 RU) is 45% higher than for MutS^ΔC800^ alone (104 RU). Since the MutS^ΔC800^/MutL^LN40^ complex is 43% larger than MutS^ΔC800^ dimer alone, this indicates that in this assay a single MutS^ΔC800^/MutL^LN40^ complex binds the DNA duplex. (**D**) Co-injection of WT MutL results in slower release from DNA than MutS^ΔC800^ alone, while uncrosslinked MutL^LN40^ only has a minor effect (traces normalized to maximum response). (**E**) While end-blocks on the DNA slow down MutS release, there is no effect on the already slow MutS^ΔC800^/MutL^LN40^ release. This is more pronounced for WT MutS, which forms more stable dimers than MutS^ΔC800^. Crosslinked MutL^LN40^ with mutations in the DNA-binding groove is deficient in the ability to retain MutS^ΔC800^ on DNA. (**F**) Normalized overlay of the 1280 nM traces from [Figure 4B,C](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.015](10.7554/eLife.06744.015)

We tested for MutL^LN40^ loading onto DNA in the context of the MutS/MutL complex in an SPR assay, comparing MutS^ΔC800^ alone with MutS^ΔC800^ crosslinked to MutL^LN40^ when it is flowed over 100-bp DNA with a G:T mismatch in the presence of ATP ([Figure 4B](#fig4){ref-type="fig"}). MutS^ΔC800^ alone displays fast release from the DNA due to ATP-dependent sliding-clamp formation ([@bib23]), as shown by the effect of blocking the end of the DNA ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). The presence of crosslinked MutL^LN40^ greatly reduces the rate of release, suggesting additional DNA binding. The magnitude of the signal in response units on a 41-bp oligomer shows that a single MutS^ΔC800^/MutL^LN40^ complex is sufficient for this effect ([Figure 4---figure supplement 1B,C](#fig4s1){ref-type="fig"}). This delay in release from DNA is also observed when using a mixture of WT MutL and MutS^ΔC800^, although to a lesser extent ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). The remaining slow release of the crosslinked complex is not affected by blocking of the free DNA end by antibody ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}) indicating that the constitutive interaction with crosslinked MutL^LN40^ completely stops MutS^ΔC800^ dissociation from DNA ends.

To validate that the slower release from DNA is indeed due to MutL^LN40^ binding to DNA, we made point mutants of the MutL^LN40^ protein and crosslinked them to MutS. Mutation R266E reduces DNA binding by MutL ([@bib39]; [@bib66]) ([Figure 4B](#fig4){ref-type="fig"}), most pronounced in full-length context. This mutation also reduces the ability of crosslinked MutL^LN40^ to retain the MutS^ΔC800^ sliding clamp on DNA ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B,F](#fig4s1){ref-type="fig"}). When introducing two additional mutations (R162E and R316E) in the MutL^LN40^ DNA binding site as suggested by the crystal structure ([Figure 4A](#fig4){ref-type="fig"}), DNA binding is completely abolished ([Figure 4C](#fig4){ref-type="fig"}) and the MutS^ΔC800^/MutL^LN40^ complex releases as fast as MutS^ΔC800^ alone ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B,F](#fig4s1){ref-type="fig"}). This indicates that MutL binds DNA when interacting with the MutS sliding clamp.

MutL is loaded onto DNA after MutS releases the mismatch, which is essential in MMR {#s2-6}
-----------------------------------------------------------------------------------

To assess whether the loading of MutL^LN40^ onto DNA is kinetically distinct from MutS mismatch recognition, we set up an assay to separate events. We read out mismatch recognition ([@bib46]; [@bib61]; [@bib69]) by the kinking of DNA, which can be assessed using 45-bp heteroduplex DNA labeled with Alexa fluorophores on each side of the mismatch ([@bib13]), [Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), in a stopped-flow set up. In parallel we follow DNA interaction using fluorescence polarization (FP) of TAMRA-labeled DNA with the same sequence. This shows that the kinking is concurrent with DNA binding by MutS^ΔC800^, while kinking is not observed when homoduplex is used ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). When the assay is performed in the presence of ATP, MutS^ΔC800^ binds and kinks the DNA but subsequently releases due to sliding clamp formation, after which an equilibrium is reached between rebinding and release ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}).10.7554/eLife.06744.016Figure 5.Implications for DNA mismatch repair initiation.(**A**) Stopped-flow FRET and FP assay shows kinking of 45-bp DNA by MutS^ΔC800^ binding only if there is a mismatch. Magnitude of FRET events are indicated by stars in the cartoon. (**B**) While MutS^ΔC800^ initially kinks the DNA and subsequently releases in the presence of ATP, the MutS^ΔC800^/MutL^LN40^ shows a secondary FP event without kinking the DNA. (**C**) Nicking assay of mismatch containing closed circular DNA (ccDNA) shows that WT or single-cysteine MutL can activate MutH, while mutations in the DNA-binding groove of MutL strongly impair the activation. (**D**) Spontaneous mutation rates after complementing MutL-deficient cells shows that the DNA-binding ability of MutL is essential for MMR in vivo. Error bars represent 95% confidence intervals. (**E**) Model for MMR initiation. After MutS undergoes an ATP-induced conformational change to allow binding of both subunits to one MutL molecule, MutL N-termini can interact and possibly dimerize, to be loaded onto DNA where MutL can activate downstream effectors.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.016](10.7554/eLife.06744.016)10.7554/eLife.06744.017Figure 5---figure supplement 1.DNA kinking by MutS^ΔC800^ and MutS^ΔC800^/MutL^LN40^.(**A**) Stopped-flow FRET and FP assay shows kinking of 45-bp DNA by MutS binding only if there is a mismatch. Separate traces for the fluorophores are shown (orange: acceptor; green: donor fluorophore; grey: FP). Size of FRET events are indicated by stars. (**B**) While MutS^ΔC800^ initially kinks the DNA and subsequently releases in the presence of ATP, the MutS^ΔC800^/MutL^LN40^ complex remains bound to unkinked DNA. (**C**) Using WT MutL (400 nM) mixed with the MutS^ΔC800^ in this assay results in more binding at equilibrium than MutS^ΔC800^ alone, while there is less FRET than for MutS^ΔC800^ alone. Under the graph with the FRET ratio (black: FRET; grey: FP), separate traces for the fluorophores are shown as in (**A**).**DOI:** [http://dx.doi.org/10.7554/eLife.06744.017](10.7554/eLife.06744.017)

In the presence of the crosslinked complex we observed a two-step sequence of events ([Figure 5B](#fig5){ref-type="fig"}). The first increase in FP is consistent with mismatch recognition by MutS^ΔC800^, simultaneous with an increase in FRET due to kinking of the DNA. A second event increases FP even more but reduces the FRET signal to below starting value ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). This can be explained by release of the mismatch (unkinking) and sliding clamp formation. Now, however, the complex does not slide off the DNA but instead the MutL^LN40^ is docked onto the DNA to keep the complex bound, as observed in the SPR assays ([Figure 4B](#fig4){ref-type="fig"}) and by the increase in FP ([Figure 5B](#fig5){ref-type="fig"}). At this time, since DNA has been pushed to the new channel, it is not kinked any more but kept relatively rigid by the MutL^LN40^ binding. This, and interaction of the fluorophore itself with bound protein, can explain the lowered FRET. A similar straightening of DNA relative to the unbound DNA was previously observed upon ATP-dependent MutS release in SAXS experiments using DNA labelled with gold-clusters ([@bib34]). The effect is also present to lesser extent when using a mixture of MutS^ΔC800^ with WT MutL in this setup ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). The result indicates that MutL^LN40^ loading occurs after mismatch recognition and sliding clamp formation by MutS^ΔC800^.

Since we observed that upon sliding clamp formation, MutS loads MutL onto DNA, we wondered whether this DNA loading step is essential for MMR. Indeed we observed a correlation with the DNA binding ability of MutL for MutH activation ([Figure 5C](#fig5){ref-type="fig"}). Moreover, the DNA-binding mutants of MutL impair in vivo MMR ([@bib66]) ([Figure 5D](#fig5){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}), indicating that loading of MutL onto DNA after mismatch recognition is essential for MMR.

Discussion {#s3}
==========

Taken together, our data reveal how the large conformational changes within MutS after mismatch recognition promote MMR activation. In the mismatch and ATP activated state MutS pushes DNA into a new channel, which allows sliding of the protein over DNA. The new state with the clamps crossed over the DNA explains the stability of the MutS sliding clamp on DNA ([@bib67]; [@bib47]; [@bib36]), as electrostatic interactions between DNA and the positive charges lining the new channel may stabilize the new clamp conformation. The conformational change pushes the connector domain away from the center and on top of the ATPase domains, to provide a second interface for the MutL protein that binds to the opposing MutS subunit, while DNA in the new MutS channel can also contribute to MutL binding. This loads the N-terminal domains of MutL onto the DNA and the MutL binding delays the sliding of MutS ([Figure 5E](#fig5){ref-type="fig"}, [Video 2](#video2){ref-type="other"}). The loading step of MutL onto DNA is required for MutH activation and nicking ([Figure 5C](#fig5){ref-type="fig"}) ([@bib39]; [@bib66]), while UvrD loading and activation at this nick ([@bib73]) would follow similar validation. In this way, the requirement of the MutS conformational change for full MutL interaction is a sophisticated validation mechanism, which presumably is conserved in the eukaryotic homologs. It ensures that repair is only initiated when necessary, and due to the MMR system DNA replication can be completed with few errors incorporated in the genome.Video 2.Model for initiation of DNA mismatch repair.After MutS (cyan/blue) has recognized a mismatch in DNA (in orange; mismatch shown as pink spheres), it will bind ATP which triggers a conformational change in which the subunits tilt across each other and the connector domains move outward. This pushes the DNA to a new channel, where MutS fits as a loose ring around the DNA duplex and can behave as a sliding clamp. The N-terminal domain of MutL (green) can specifically recognize this state by binding two interfaces simultaneously. This loads MutL onto the DNA, where the N-terminal domains could dimerize and downstream effectors can be activated.**DOI:** [http://dx.doi.org/10.7554/eLife.06744.018](10.7554/eLife.06744.018)10.7554/eLife.06744.018

The complete transition from mismatch binding to sliding clamp state is likely to take multiple steps ([@bib65]). First a single ATP will bind, leading to a stabilized asymmetric nucleotide state of MutS on the mismatch ([@bib3]; [@bib4]; [@bib57]), followed by binding of the second ATP ([@bib52]; [@bib28]). Meanwhile MutS will undergo two separate ATP-induced events, the tilting of the subunits that push DNA into a new channel and the rearrangement of the connector domain (and the associated mismatch binding domain) that together generate a new MutL interface.

These two movements could potentially be uncoupled. MutS binding to a non-hydrolysable ATP analog can already cause a closed clamp-like state, (i.e. perform the tilting movement) as supported by SAXS analysis ([@bib33]), but may possibly not change the conformation of the mismatched binding domain ([@bib65]), as consequence of the connector domain movement. This would explain how MutS with ATPγS (or with ATP for a mutant that cannot hydrolyse nucleotides \[E694A\] \[[@bib35]\]) could form a closed clamp state that can no longer be loaded onto DNA ([@bib21]; [@bib35]; [@bib13]), but nevertheless is not sufficient to bind MutL.

Our data do not address the order of the two events, tilting and connector movement, or how they relate to the two ATP binding events. Observed conformational changes resulting in ternary complex and sliding clamp formation have previously been suggested to be independent ([@bib56]). Indeed our structure does suggest that rearrangement of a single connector domain (in the subunit equivalent to the 'MSH2' subunit; ([@bib54]) is sufficient for the complex formation with MutLα ([@bib29]; [@bib28], [@bib27]). This might allow MSH6 to initially remain bound to the mismatch, consistent with models that consider transient asymmetric nucleotide states involved in mismatch verification and possibly ternary complex formation ([@bib3]; [@bib29]; [@bib48]; [@bib52]; [@bib28]; [@bib57]; [@bib65]). Another question that is unclear is where the loading of MutL onto DNA takes place. It could occur on or close to the mismatch itself, but it is also possible that MutS first slides before loading MutL on DNA.

Once the sliding clamp conformation is reached, the complex no longer interacts with the mismatch ([@bib20]). The clamp state loads MutL onto DNA, stabilizes a straight form of the DNA ([Figure 5B](#fig5){ref-type="fig"}) ([@bib34]) and triggers the conformational changes of MutL. These involve movements in the C-terminal domains ([@bib24]) to form a ring around the DNA and ATP binding by the N-terminal domains of MutL to generate the state that activates MutH and UvrD ([@bib64]; [@bib15]; [@bib7]; [@bib1]).

In conclusion, we have used single-cysteine mutants and chemical crosslinking to trap and analyze a relevant MMR intermediate state that has long been elusive. This sliding clamp state of MutS bound to a MutL domain is highly informative. It corresponds to a reaction intermediate that occurs during a series of conformational changes triggered by mismatch recognition, and explains why specifically this conformation of MutS is able to recruit MutL. The presented combination of structural and biophysical methods provides a powerful approach to resolve conformational changes within large and transient protein complexes that form and act during biologically relevant processes.

Materials and methods {#s4}
=====================

Proteins {#s4-1}
--------

MutS mutants were created in the *mutS* gene in vector pET-3D ([@bib46]; [@bib18]; [@bib51]; [@bib71]) or vector pET15b ([@bib51]; [@bib71]) (for His-tagged MutS constructs in FRET assays). MutL mutants were generated in the *mutL* gene in plasmid pTX418 ([@bib17]; [@bib8]). Single-cysteine MutS and MutL constructs were obtained as described ([@bib18]; [@bib23]). Mutant and WT MutS and MutL proteins were purified as described previously ([@bib46]; [@bib51]), except that in the buffers KCl was used instead of NaCl (final gel filtration buffer for MutS: 25 mM Hepes pH 7.5, 150 mM KCl, 1 mM DTT; for MutL: 20 mM Tris pH 8.0, 0.5 M KCl, 10% glycerol, 1 mM DTT).

MutH was purified as follows: *E. coli* BL21(DE3) cells were transformed with MutH expression plasmid pTX417 ([@bib17]) and plated onto LB agar with 50 μg/ml carbenicillin. A colony was picked and cells were grown in LB with 50 μg/ml carbenicillin at 37°C to OD600 ∼0.6 and induced with 1 mM isopropyl 1-thio-β-D-galactopyranoside for 4 hr. Cells were harvested and resuspended in binding buffer (25 mM Tris pH 8.0, 300 mM KCl, 10 mM imidazole, 0.2 mM DTT) with 1 mM PMSF and protease inhibitors (Roche Diagnostics, F. Hoffmann-La Roche Ltd, Switzerland) and lysed by sonication. The cleared supernatant was incubated with Talon resin (Clonetech Laboratories, Takara holdings inc, Japan) for 30 min on ice. Beads were washed using binding buffer with 1 M KCl, and MutH was eluted with 250 mM imidazole in binding buffer. The His-tag was removed by cleavage with Thrombin protease (∼5 units thrombin/mg MutH; GE Healthcare, Fairfield, California) while dialyzing against 20 mM Tris pH 8.0, 100 mM KCl, 0.2 mM DTT for 2 hr at 22°C followed by overnight incubation at 4°C. The mixture was brought to 20 mM imidazole, incubated with Talon beads to remove uncleaved protein, and loaded onto a heparin column equilibrated in buffer A (25 mM Tris pH 8.0, 0.1 M KCl, 1 mM DTT). MutH was eluted using a gradient of 0.1--1.0 M KCl in buffer A, pooled and diluted twofold with buffer A and loaded onto a MonoQ column equilibrated with buffer A. MutH was eluted using the same gradient, pooled and dialyzed overnight against 25 mM MES pH 5.5, 150 mM KCl, 1 mM DTT. MutH was loaded onto a MonoS column equilibrated with 25 mM MES pH 5.5, 0.1 M KCl, 1 mM DTT and eluted using a 0.1--1.0 M KCl gradient. Peak fractions were pooled, concentrated using Centriprep 10 and loaded onto a Superdex 75 column equilibrated with 25 mM Tris pH 8.0, 250 mM KCl, 1 mM DTT. Peak fractions were pooled, concentrated, flash frozen in 25 mM Tris pH 8.0, 250 mM KCl, 1 mM DTT, 50% glycerol and stored at −80°C.

Small-scale protein crosslinking {#s4-2}
--------------------------------

Single cysteine MutS^ΔC800^ and His-tagged MutL^LN40^ proteins were reduced with 10 mM DTT for 20 min and O/N dialyzed into buffer B (25 mM Hepes pH 7.5, 400 mM KCl, 5 mM MgCl~2~, 10% glycerol) at 4°C, to remove DTT. MutS^ΔC800^ (0.57 μM) was incubated with 100-bp DNA containing a G:T mismatch (AAACAGGCTTAGGCTGGAGCTGAAGCTTAGCTTAGGATCATCGAGGATC[G]{.ul}AGCTCGGTGCAATTCAGCGGTACCCAATTCGCCCTATAGGCATCCAGGTT annealed with AACCTGGATGCCTATAGGGCGAATTGGGTACCGCTGAATTGCACCGAGCT[T]{.ul}GATCCTCGATGATCCTAAGCTAAGCTTCAGCTCCAGCCTAAGCCTGTTT, 0.29 μM) for 25 min on ice in buffer C (25 mM Hepes pH 7.5, 125 mM KCl, 5 mM MgCl~2~). MutL^LN40^ (4 μM) was incubated with 5 mM ATP for 25 min on ice. MutS^ΔC800^/DNA and MutL^LN40^/ATP samples were then combined to final protein concentrations 0.4 μM (DNA concentration 0.2 μM) and additional ATP was added to a final concentration of 1 mM. Samples were then incubated for 10 min at RT, after which they were adjusted to 37°C for 2 min. Crosslinker (BMOE or BM\[PEO\]~3~, Pierce, Thermo Fisher scientific, Waltham, MA, dissolved to 0.5 mM in DMSO) was added to a final concentration of 50 μM and samples were incubated for exactly 2 min at 37°C. Reactions were stopped by adding protein loading buffer with DTT and crosslinking was assessed on SDS-PAGE gels stained with coomassie.

MutS^ΔC800^/MutL^LN40^ complex purification {#s4-3}
-------------------------------------------

To obtain crystallizable amounts of crosslinked MutS^ΔC800^/MutL^LN40^ complex, equimolar amounts of MutS^ΔC800^ D246C and His-tagged MutL^LN40^ N131C (or with additional arginine mutations) were reduced and dialyzed separately, as described above. MutL^LN40^ was diluted to 2 μM in buffer D (25 mM Hepes pH 7.5, 400 mM KCl, 10% glycerol) and incubated with a 5-fold molar excess of BM(PEO)~3~ (from 50 mM solution in DMSO) for 10 min at 4°C. The low MutL^LN40^ concentration prevented the formation of MutL^LN40^-MutL^LN40^ crosslinks, while the excess crosslinker ensured each MutL^LN40^ to react with one maleimid group so that the other reactive side of the crosslinker remained available. The MutL^LN40^ was then bound to Talon beads and the beads were subsequently washed with 20 column volumes of buffer D and 20 column volumes of buffer E (25 mM Hepes pH 7.5, 150 mM KCl, 10% glycerol, 5 mM imidazole) to remove excess crosslinker. MutS^ΔC800^ was incubated for 10 min with equimolar amounts of 30-bp DNA with a G:T mismatch at position 9 (AGCTGCCA[G]{.ul}GCACCAGTGTCAGCGTCCTAT annealed with ATAGGACGCTGACACTGGTGC[T]{.ul}TGGCAGCT) in buffer C. The DNA-bound MutS^ΔC800^ was then added to the Talon-bound MutL^LN40^, and 30-fold excess ATP was immediately added after which everything was incubated to crosslink for 1 hr at 4°C. The beads were then washed with 10 column volumes buffer E to remove MutS^ΔC800^-MutS^ΔC800^ crosslinks, after which the protein was eluted in buffer E with 300 mM imidazole and DTT was added to quench excess crosslinker. The protein was bound to a 5 ml heparin column (GE Healthcare, Fairfield, California) and eluted with a 0.1--1 M KCl gradient, which removed the DNA from the protein. The elution was subsequently concentrated and purified with size-exclusion chromatography in buffer B containing 1 mM DTT, for which two S200 16/60 columns were coupled resulting in one long column. The MutS^ΔC800^/MutL^LN40^ protein peak was then concentrated, after which the MutS^ΔC800^ concentration was estimated using ε = 95,238 and the whole process (including DTT incubation and dialysis) was repeated to obtain S~2~L~2~ complexes. The resulting protein (5--10% final yield) was concentrated to 80--90 μM (expressed in MutS monomer concentrations; ε = 94,660) and flash-frozen until further use.

Crystallization and structure solution {#s4-4}
--------------------------------------

For crystallization, 50 μM MutS^ΔC800^/MutL^LN40^ complex was incubated with 25 μM DNA containing a G:T mismatch (27-bp: TGCCA[G]{.ul}GCACCAGTGTCAGCGTCCTAT annealed with ATAGGACGCTGACACTGGTGC[T]{.ul}TGGCA or 100-bp, same sequence as above) for 25 min on ice. AMP-PNP was subsequently added to a concentration of 1 mM and the protein was crystallized at 4°C using vapor diffusion in 9--12% PEG-8000, 100 mM Tris pH 7.0, 200 mM MgCl~2~, and 80--450 mM sodium malonate. Microseeding was used to increase crystal nucleation. Crystals were cryoprotected in mother liquor supplemented with 25% ethylene glycol and 100 mM KCl before flash-cooling in liquid nitrogen. Diffraction data were collected at 100 K at beamline ID-29 at the ESRF or beamline PX-III at the SLS.

Crystallographic data were processed with XDS ([@bib40]) or iMOSFLM ([@bib63]) and scaled using Aimless from the CCP4 suite ([@bib72]). Crystal structures were solved in consecutive steps of finding domains using Phaser ([@bib53]). Several search models were used, but best results were obtained with domains from chain A of PDB entry 1W7A as search models for MutS^ΔC800^ and chain A from PDB entry 1BKN for MutL^LN40^, while clear density for residues 150--164 of MutL^LN40^ allowed building as in PDB entry 1NHJ. The search process was improved by going back and forth between the different datasets to find missing domains. Initial structure solution was performed starting from crystal form 1 as follows: first, a search model consisting of residues 267--800 of chain A of PDB entry 1W7A (MutS) was searched twice using Phaser, which resulted in a solution with these chains forming a tilted MutS dimer. Next, this solution was used together with a search model consisting of chain A of 1BKN (MutL^LN40^), which placed this protein against the ATPase domain of one MutS subunit. Then, the second MutLLN40 was found with Phaser using a brute rotation search of 15° around the angle that would orient this MutL^LN40^ on the other side of the MutS dimer in a similar manner as the first, and automated translation, packing and refinement steps by Phaser indeed placed the MutL^LN40^ in the symmetrically equivalent position. One connector domain (residues 128--266 of chain A of 1W7A) was then found with Phaser, and the second connector domain was placed using similar steps as for the second MutL^LN40^ search. Thus the search identified the equivalent dimeric counterpart three times for separate parts of the complex (the main MutS chain, MutL^LN40^ and connector domains). The resulting MutS-MutL^LN40^ complex structure could then be used as a search model in all crystal forms and easily identified equivalent complexes in each of those (present three times in the asymmetric units in the 6.6 Å and 7.6 Å datasets). Finally, for crystal form 1, an additional 'half complex' was found with Phaser using one MutS chain and one MutL^LN40^ chain of the existing complex structure. This second complex forms a symmetry-generated dimer over a twofold axis, with similar MutS-MutL^LN40^ interfaces, but the MutS clamp domains in this crystallographic dimer could not be modeled. This second conformer forms a more compact MutS dimer, probably due to crystal packing, but since it has identical interfaces with MutL^LN40^ we focussed on the main conformation throughout this paper. Excellent quality of the structure solutions after molecular replacement with the complete but unrefined models is evident from the Phaser statistics: TFZ = 9.0/LLG = 996 for 4.7 Å; TFZ = 14.2/LLG = 899 for 6.6 Å; and TFZ = 13.0/LLG = 795 for the 7.6 Å dataset.

Refinement was first performed using rigid body refinement in REFMAC5 ([@bib59], [@bib58]), for which the following domains of MutS were defined: residues 128--266, 267--765, 766--800; and for MutL: residues 20--204, 205--331. Next, limited restrained refinements were performed, first using ProSMART-generated external restraints ([@bib60]) to the PDB_REDO-optimized ([@bib38]) entries of chain A of 1W7A and chain A of 1BKN in order to ensure consistency with prior observations, followed by TLS and jelly-body refinement in latter stages. PDB_REDO-optimized homologues were used for external restraint generation in order to maximize reliability of the prior structural information. All refinements were performed using REFMAC5 ([@bib59], [@bib58]). During refinement, clear density became visible for missing residues 150--164 of the MutL^LN40^ subunits, which followed the conformation of PDB entry 1NHJ. Interestingly, this conformation was different from that in the MutL search model state, indicating this to be real signal, and not due to bias from the search model. Also, AMP-PNP could be placed in density in the nucleotide binding sites of MutS. During intermediate stages, PDB_REDO and MolProbity ([@bib11]) were used to correct geometry and perform side-chain flips. After refinement, all structures were in the 97th--100th Clashscore and 98th--100th MolProbity score percentiles. Refinement and data collection statistics can be found in [Table 1](#tbl1){ref-type="table"}. Figures and videos were generated with MacPyMOL (<http://www.pymol.org>), interpolations between conformations were created with LSQMAN ([@bib42]) and electrostatic surface with CCP4mg ([@bib72]). Protein interface areas were calculated using PISA ([@bib72]) for which the missing loop of residues 126--131 of MutL^LN40^ in interface 2 was modeled as in PDB entry 1NHJ.

MutS conformational changes {#s4-5}
---------------------------

To look at changes within MutS dimers, we used MutS D835R dimer ([@bib51]; [@bib23]) variants that do not form tetramers, with single cysteines in positions R449C (His-tagged), D246C, S798C, or A336C. The proteins were labeled with Alexa Fluor 488 or Alexa Fluor 594 maleimide (Invitrogen, Thermo Fisher scientific, Waltham, MA) according to the manufacturers instruction. Excessive dye was removed using Zeba Spin Desalting columns (Thermo Fisher scientific, Waltham, MA) and the degree of labeling determined from the absorbance spectra recorded from 220--700 nm (nanodrop) according to the manufactures instructions.

Clamp-domain crossover movement and connector domain movement within MutS dimers were measured using FRET in which fluorescence emission spectra were recorded with excitation at either 485 nm (5 nm slit width) for FRET or 590 nm (5 nm slit width) for direct acceptor measurements. FRET was determined by the ratio between signal at 485 and 615 nm while direct acceptor was determined by the ratio between signal at 590 and 615 nm and after correction for spectral crosstalk the ratio FRET/acceptor was calculated, and normalized for unbound protein. Heterodimers of single-cysteine MutS variants labeled with Alexa Fluor 488 and Alexa Fluor 594, respectively, were allowed to form by mixing 200 nM of each protein and incubation at 22°C for at least 30 min in the absence of ADP in buffer F (25 mM Hepes pH 7.2, 150 mM KCl and 5 mM MgCl~2~) supplemented with 0.05% TWEEN-20. Next, 200 nM of 59-bp DNA with a G:T mismatch (TGAAGCTTAGCTTAGGATCATCGAGGATC[G]{.ul}AGCTCGGTGCAATTCAGCGGTACCCAATT annealed with AATTGGGTACCGCTGAATTGCACCGAGCT[T]{.ul}GATCCTCGATGATCCTAAGCTAAGCTTCA, with blocked ends as described above) was added, followed by addition of 1 mM ATP. As a homoduplex control 240 pM λ-DNA (corresponding to 200 nM of the 59 bp blocked Heteroduplex-DNA) was used.

MutS-DNA FRET was measured in a Hitachi Fluorescence spectrofluorimeter F-4500 (Hitachi Ltd, Japan) (Program FL Solutions 2.0). Fluorescence emission spectra (600--700 nm) were recorded with excitation at either 435 nm (5 nm slit width) for FRET or 590 nm (5 nm slit width) for direct acceptor measurements. FRET was determined by the ratio between signal at 435 and 615 nm while direct acceptor was determined by the ratio between signal at 590 and 615 nm and after correction for spectral crosstalk the ratio FRET/acceptor was calculated. We used 30-bp DNA with or without a G:T mismatch (AATTGCACCGAGCT[T]{.ul}GATCCTCGATGATCC annealed with complementary strand or GGATCATCGAGGATC[G]{.ul}AGCTCGGTGCAATT), where the T-containing strand had 5\' and 3\' digoxigenin labels so that both DNA ends were blocked with anti-digoxigenin Fab fragments (Roche Diagnostics, F. Hoffmann-La Roche Ltd, Switzerland). 100 nM of the DNA with 6 µM SYTOX Blue (Invitrogen, Thermo Fisher scientific, Waltham, MA) was mixed with 200 nM MutS variants labeled with Alexa Fluor 594 in buffer F, after which ATP was added to 1 mM to induce the conformational change in MutS.

In vivo MMR complementation {#s4-6}
---------------------------

Spontaneous mutation rates were assessed using acquired rifampicin resistance. Strains KR1517 (*mutS*, as in \[[@bib45]\]) or GM4250 (gift from M Marinus, \[[@bib5]\]) (*mutL*) were transformed with empty vector or plasmid containing WT or mutant MutS or His-MutL genes, and plated on LB/agar plates with 50 μg/ml carbenicillin and 30 μg/ml kanamycin. After overnight incubation at 37°C, single colonies were picked and grown in 10 ml LB with antibiotics to OD~600~ ∼1.0. Next, 0.33 × 10^8^ or 1 × 10^8^ cells were plated on LB plates with antibiotics and 0.1 mg/ml rifampicin. Plates were O/N incubated at 37°C and rifampicin resistant colonies were counted. Mutation rates and 95% confidence intervals were determined using Fluctuation AnaLysis CalculatOR with the MSS maximum-likelihood method (<http://www.mitochondria.org/protocols/FALCOR.html>).

DNA binding kinetics {#s4-7}
--------------------

SPR experiments for binding MutS^ΔC800^ D246C or crosslinked MutS^ΔC800^/MutL^LN40^ complex to DNA were performed in a Biacore T200 system (GE Healthcare, Fairfield, CA) as described ([@bib23]). The experiments were performed in SPR buffer containing 25 mM Hepes pH 7.5, 150 mM KCl, 5 mM MgCl~2~, 1 mM DTT, 0.05% TWEEN-20 and 1 mM ATP, using immobilized biotinylated 100-bp DNA (same sequence as above) with a fluorescein moiety at the other end.

MutL-MutS binding assay {#s4-8}
-----------------------

Full-length His~6~-MutL binding to the full-length MutS sliding clamp was assessed using a two-step SPR assay. The resulting graphs are not strictly affinity curves, as changes in MutS stability on DNA contribute to the observed response, but serve to assess the effect of mutations. The SPR buffer was supplemented with 20% glycerol to ensure MutL stability. Before every measurement, anti-fluorescein Fab fragment (Invitrogen, Thermo Fisher scientific, Waltham, MA) was injected to block the fluorescein-labeled DNA (100 bp, see above) ends. MutS sliding clamps were captured on the end-blocked DNA by injecting 200 nM WT or mutant MutS protein (in buffer with 1 mM ATP) for 120 s. Then WT or mutant MutL protein (in buffer with 1 mM ATP) was injected for 120 s, followed by dissociation with buffer only. This was repeated with varying concentrations of MutL.

DNA binding by MutL {#s4-9}
-------------------

Fluorescence polarization measurements to assess DNA-binding of MutL^LN40^ mutants were performed in low-salt FP buffer with 25 mM Hepes pH 7.5, 50 mM KCl, 5 mM MgCl~2~, 1 mM DTT and 0.05% TWEEN-20. For full length MutL, the buffer was supplemented with 10% glycerol. A concentration of 0.5 nM of 5′ labeled TAMRA-41-bp DNA (ATAGGACGCTGACACTGGTGCTTGGCAGCTTCTAATTCGAT annealed with complementary strand) was used. MutL proteins were serial diluted in black 96-well microplates (PerkinElmer Inc, Waltham, MA) in 100 μl volumes. Polarization of the TAMRA label was read out in a PHERAstar FS machine (BMG Labtech GmbH, Germany) with an 540/590 (excitation/emission) FP module.

DNA kinking assays {#s4-10}
------------------

Stopped-flow assays to assess DNA binding and kinking were performed in buffer containing 25 mM Hepes pH 7.5, 150 mM KCl, 5 mM MgCl~2~, 1 mM DTT, 0.05% TWEEN-20 and 10 μM ADP, with or without 1 mM ATP. One syringe contained 100 nM of 45-bp DNA with or without a G:T mismatch (GTCATCCTCG\[T\*\]CTCAAGCTGCCA[G]{.ul}GCACCAGTGTCAGCGTCCTAT annealed with complementary strand or ATAGGACGC\[T\*\]GACACTGGTGC[T]{.ul}TGGCAGCTTGAGACGAGGATGAC) which was either labeled with Alexa Fluor 594 at position 11 in the top strand and Alexa Fluor 488 at position 10 in the bottom strand (indicated by T\*), or with 5′-labeled with TAMRA in the top strand. The other syringe contained 400 nM MutS^ΔC800^ D246C or crosslinked MutS^ΔC800^/MutL^LN40^ complex. For assays with double-labeled DNA, donor fluorophores were excited at 473 nm and measured using filters 540IB + 540IK, while acceptor fluorophores were measured at the same time using an OG590 filter. For experiments with TAMRA-labeled DNA, the fluorophore was excited at 545 nm and OG540 filters were used for read-out. Samples were co-injected in a KinetAsyst SF-61DX2 stopped-flow machine (TgK Scientific, UK) fitted with R10699 photomultiplier tubes (Hamamatsu Photonics K.K., Japan) at 15°C and measured for 100 s, which was repeated 5--10 times and averages were calculated.

MutH activation assay {#s4-11}
---------------------

Circular DNA containing a single G:T mismatch and 12 hemi-methylated GATC sites was prepared via primer extension on single stranded DNA from a derivative of pGEM-13Zf (gift from J Jiricny) as described ([@bib6]) with the exception that closed circular DNA was purified from gel using a Wizard gel purification kit (Promega Corporation, Madison, WI). To enable quantification, an Alexa Fluor 647 labeled oligo (IBA GmbH, Germany) was used: CCAGACGTCTGTC[G]{.ul}ACGTTGGGAAGCT\[T\*\]GAGTATTCTATAGTGTCACCT, where the [G]{.ul} is nucleotide forming a G:T mismatch and the T\* is the Alexa Fluor 647 labeled nucleotide. Nicking reactions contained 25 mM Hepes KOH pH 7.5, 150 mM KCl, 0.1 mg/ml BSA, 5 mM MgCl~2~, 1 mM DTT, 1 mM ATP, 0.5 nM circular DNA, 200 nM MutS, 200 nM WT MutL, single-cysteine MutL N131C, MutL N131C R266E or MutL N131C R162E/R266E/R316E and 100 nM MutH as well as twofold dilutions thereof. Control reactions contained either no protein or 200 nM MutS and 100 nM MutH. Reactions were incubated for 5 min at 37°C and stopped with an equal volume of 20% glycerol, 1% SDS and 50 mM EDTA. Samples were analyzed on 0.8% agarose gels supplemented with 1 µg/ml ethidium bromide, run in 1x TAE. Conversion of covalently closed circles into nicked product was visualized using the fluorescence of the Alexa Fluor 647 label using a Typhoon Trio Imager (GE Healthcare, Fairfield, CA) with excitation at 633 nm and emission filter 670BP30.

ATPase assay {#s4-12}
------------

ATPase activity of WT MutS and MutS P595A/I597A/M759D was measured by coupling ATP hydrolysis to oxidation of NADH as in ([@bib45]). MutS protein (5 μM) was mixed with 3.125--500 μM ATP and hydrolysis was measured in a spectrophotometer during 5 min.

MutL^LN40^ dimerization assay {#s4-13}
-----------------------------

Crosslinked MutS^ΔC800^/MutL^LN40^ complex (1 mg/ml) was incubated for 5 min on ice with equimolar amounts of 100-bp DNA containing a G:T mismatch (sequence as in main text). MutL^LN40^ (2 mg/ml) was incubated with the MutS^ΔC800^/MutL^LN40^/DNA complex or with DNA only, and 1 mM AMP-PNP as described ([@bib8]). Samples were injected onto a S200 5/150 column in buffer containing 20 mM Tris pH 8.0, 150 mM KCl, 0.1 mM EDTA, 5 mM MgCl~2~, 1 mM DTT and 5% glycerol. Eluted fractions were analyzed on SDS-PAGE stained with coomassie.
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Groothuizen FS, Winkler I, Cristovao M, Fish A, Winterwerp HHK, Reumer A, Marx AD, Hermans N, Nicholls RA, Murshudov GN, Lebbink JHG, Friedhoff P, Sixma TK, 2015,MutS in complex with the N-terminal domain of MutL---crystal form 1,<http://www.rcsb.org/pdb/explore/explore.do?structureId=5akb>,Publicly available at the RSCB Protein Data Bank (Accession no 5AKB).

Groothuizen FS, Winkler I, Cristovao M, Fish A, Winterwerp HHK, Reumer A, Marx AD, Hermans N, Nicholls RA, Murshudov GN, Lebbink JHG, Friedhoff P, Sixma TK, 2015,MutS in complex with the N-terminal domain of MutL---crystal form 2,<http://www.rcsb.org/pdb/explore/explore.do?structureId=5akc>,Publicly available at the RSCB Protein Data Bank (Accession no 5AKC).

Groothuizen FS, Winkler I, Cristovao M, Fish A, Winterwerp HHK, Reumer A, Marx AD, Hermans N, Nicholls RA, Murshudov GN, Lebbink JHG, Friedhoff P, Sixma TK, 2015,MutS in complex with the N-terminal domain of MutL---crystal form 3,<http://www.rcsb.org/pdb/explore/explore.do?structureId=5akd>,Publicly available at the RSCB Protein Data Bank (Accession no 5AKD).

Standard used to collect data: PDB validation reports are supplied.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "MutS/MutL crystal structure reveals that the mutS sliding clamp loads MutL onto DNA" for consideration at *eLife*. Your article has been favorably evaluated by John Kuriyan (Senior editor) and three reviewers, including Leemor Joshua-Tor (Reviewing editor), and Randy Read.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This is a strong paper describing a thorough study of the implications of the structure of a trapped MutS:MutL complex on the mechanism of DNA mismatch repair. The structural studies accompanied by FRET, crosslinking and binding studies show that MutS is converted to a sliding clamp conformation to load MutL onto DNA. The paper is well written and clear despite covering a lot of material. The crystal structures along with analyses resulting in many new insights provide at least two major breakthroughs: the MutS ATP bound conformation and the requirement of the MutS conformational change for functional MutL interaction: together these provide an elegant regulatory mechanism for commitment to repair. The additional analysis and testing via mutants, gels, FRET and SPR provide substantial added impact. This is likely to be one of the most important sets of structural results for the DNA mismatch repair field in the last 5 years. There are many novel insights that come directly from these structures and associated analyses, such as the ATP-bound MutS conformation and the rearrangement of the connector domain that creates a second interface with MutL to regulate pathway progression. Moreover, this work certainly advances our understanding of macromolecular machines in general.

The starting point for this study is the determination of the structure of trimmed constructs of MutS and MutL that have been trapped in a transient conformation by crosslinking Cys side chains that are sufficiently close only in the sliding clamp conformation. The process of producing enough stable MutS/MutL dimer for crystallization efforts is itself impressive. The structures are without a doubt important and interesting. Three crystal forms were obtained, and all diffract to relatively low resolution with the best being 4.7Å. At this resolution, care must be taken in structure solution and refinement to overcome the poor parameter:data ratio. The validity of the molecular replacement structure solution is pretty much beyond question, as the statistics for the placement of components are convincing and, of much greater importance, the same complex has been assembled more than once in the course of structure solution. The refinement has been carried out with care to avoid over-fitting, as indicated by the low values for *R*~free~ and the presence of unbiased features showing unmodelled loops and expected ligands. In addition, all the important conformational changes and molecular contacts inferred from the structure have been checked by FRET measurements and cross-linking experiments.

As the authors point out: "During refinement, clear density became visible for missing residues 150-164 of the MutL^LN40^ subunits, which followed the conformation of PDB entry 1NHJ. Interestingly, this conformation was different from that in the MutL search model state, indicating this to be real signal, and not due to bias from the search model." In analyzing the structures, the authors make several good points in relating the current results to other established data. However, as the MMR field has ongoing strong controversies regarding the sliding clamp and MutL interactions, it will be important to place this exciting new data as firmly as possible into the context of other biophysical work.

The reviewers raised several issues that should be addressed in a revised manuscript:

As mentioned, the findings in this paper are substantial and some aspects of the results did not receive a complete discussion in light of other observations in the field. The reviewers discussed the possibility of suggesting a split into two papers, however, this would slow down the process considerably. Instead, since there is no space limitation, the authors are encouraged to expand their Discussion as pointed out below.

Specific comments:

1\) According to section 7 of the submission guidelines, crystal structures must be deposited and the PDB validation reports must be provided to the referees. The referees should have a chance to examine these reports before the paper is accepted, and the PDB codes should be given in the text.

2\) In the Abstract, the statement about the structure being based on cysteine crosslinking could be misread as indicating that this was a hybrid structure based largely on inferred distances. It would be better to clarify in the Abstract that the desired conformation was trapped by cysteine crosslinking and that crosslinking experiments were also used to validate the molecular interactions inferred from the structure.

3\) Several experiments are presented -- FRET, binding, crosslinking -- however, in most a control with non-mismatched DNA is missing. There are claims such as "dependent on mismatched DNA" that could not be made without these controls. Some of the FRET experiments should also be done with non-hydrolyzable ATP in addition to ATP. For the FRET experiments -- the data in supplementary material should include donor and acceptor curves, rather than just final FRET differences.

4\) The presentation is clear and concise, but it is disappointing that more of the paper was not devoted to describing the crystal structures plus their relationships to transient states, as together they answer many questions. For example, the packing within the crystal structure, as a potential filament on DNA, is of particular interest to many but left as supplement. An expanded discussion should address the transient states, the specificity and effect of MutL binding to MutS, and the new channel resulting from a novel conformation of MutS that reveals a rearrangement of the subunits in the MutS^ΔC800^ dimer.

5\) Importantly, this work establishes the ATP-bound conformation for MutS dimer with a greater motion than expected from prior MutS structures. In this novel MutS conformation the subunits are tilted across each other by ∼30{degree sign} which explains the stability of the MutS sliding clamp on DNA, compared to the mismatch recognition state. More detail on how this compares to the Rad50 ABC ATPAse ATP-bound conformation would be useful to readers, as the use of ABC ATPases in both mismatch and double-strand break repair has sparked considerable interest. E.g. the ABC ATPase signature helix identified from Rad50 conveys ATP-binding to Rad50 conformations, is this similar or different in the MutS changes in concert with ATP and MutL (Williams GJ et al., ABC ATPase signature helices in Rad50 link nucleotide state to Mre11 interface for DNA repair. Nat Struct Mol Biol. 2011 Apr;18(4):423-31)? Such conformational switching in Rad50 controls pathway progression and the choice between DNA end joining and excision, which may have parallels to these new MutS results or not (Deshpande RA et al., ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling. EMBO J. 2014 33, 482-500).

6\) The authors\' state that the "... sliding clamp state of MutS bound to a MutL domain is highly informative." However their point that "it corresponds to a reaction intermediate that occurs during a series of conformational changes triggered by mismatch recognition" depends upon putting this work firmly into the context of existing results. Given the novel conformation of MutS and low-resolution coupled to issues from the heavy reliance on Cys mutants, cross-linked and truncated constructs and the absent electron density for the DNA, the authors would do well to better relate this work to other recent biophysical results where feasible, e.g. Gorman J, et al., Single-molecule imaging reveals target-search mechanisms during DNA mismatch repair. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3074-83 and DeRocco VC, Sass LE, Qiu R, Weninger KR, Erie DA. Dynamics of MutS-mismatched DNA complexes are predictive of their repair phenotypes. Biochemistry. 2014 Apr 1;53(12):2043-52.

7\) The authors also point out that their presented combination of structural and biophysical methods provides a powerful approach to resolve conformational changes within large and transient protein complexes. Thus, it would be useful to relate this model to recent data on the comprehensive conformational states for MutS and the model for bending then straightening steps in MutS damage recognition. X-ray scattering data was interpreted to suggest that nucleotide binding drives MutSβ conformational changes (Hura GL et al., Comprehensive macromolecular conformations mapped by quantitative SAXS analyses. Nat Methods. 2013 Jun;10(6):453-4.) These new observations would seem to be in general agreement with the SAXS results, e.g. "As this is measured in the absence of MutL it suggests that after mismatch binding, ATP is sufficient to induce movement of the connector domain away from the mismatch-recognition position."

8\) For the crosslinked complex, the authors observe a two-step sequence of events, a first increase in FP simultaneous with an increase in FRET due to kinking of the DNA, then a second event increases FP even more but reduces the FRET signal to below starting value in which "... the DNA is not kinked any more but kept relatively rigid by the MutL" -- these data seem to support and extend results from X-ray scattering, which showed DNA bending then straightening upon formation of MutS/MutL complexes (Hura GL et al., DNA conformations in mismatch repair probed in solution by X-ray scattering from gold nanocrystals. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17308-13).

9\) They do not observe the DNA in these structures. They claim that either the DNA is disordered (sliding along the channel that is formed) or that it was released. Could this be experimentally examined? Though not complete verification, were the crystals examined to see whether DNA was in the crystals? In one of the crystal forms the channels of at least 3 copies are aligned -- if the DNA is in there -- it might show fiber scattering along that axis. Do they see this? Would the DNA be able to stack along there (due to length)? Though they may not have a 2:2:1 complex anymore.

10\) In the Introduction, around the third paragraph, it would be good to help out the uninitiated reader by noting that the newly replicated strand is recognised by the lack of adenine methylation.

11\) In the first paragraph of the Results, it would be good to mention the nature and length of the crosslinker. Until a clarification in the subsection "MutS sliding clamp recognition by MutL", it could appear that the authors were referring to disulphide bridge formation.

12\) In the second paragraph of the Results, the phrase "purification to obtain the protein in two successive cycles" should be clarified. Does this means that two purification steps were carried out?

13\) In the second paragraph of the subsection "MutS sliding clamp recognition by MutL", it is not really appropriate to compare the 15.5Å distance between C-alpha atoms of Cys residues with the 18Å distance (really 17.8Å according to the Pierce information) between C atoms in the maleimide ring. In the cross-linked state, there will be three additional bonds on each side (CA-CB-SG-C), giving a significantly larger maximum distance between C-alpha atoms.

14\) In the legend to [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}, there should be a capital "D" in the definition of the difference map coefficients, i.e. "mFo-DFc". The authors should always indicate what types of electron density maps are presented (supplementary figures).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled "MutS/MutL crystal structure reveals that the mutS sliding clamp loads MutL onto DNA" for further consideration at *eLife*. Your revised article has been favorably evaluated by John Kuriyan (Senior editor), a Reviewing editor, and two reviewers. The manuscript has been improved significantly but there are some remaining issues that need to be addressed before acceptance, which should be expedient at that point. These are outlined below.

Overall this is an impressive and high impact manuscript on the MutS-MutL structure. The large and functionally-important conformational change seen in MutS with MutL and nucleotide binding fills a big gap in our understanding with likely broad impacts as noted below. Also for the most part, the authors have addressed the reviewers\' comments. However, there are some responses where the authors should take another look. Given the importance of this work, in order to more clearly position it in the field, and improve the impact this paper would have, the authors should consider the following 5 points before publication.

1\) In response to point 5 about how this new work related to the Rad50 ABC ATPase family member (specifically recent NSMB and EMBO papers), they mention that while "the signature helix itself is indeed important ... and the new position of the connector domain is overlapping with the position of the coiled coil regions in Rad50 in the AMP-PNP bound state" the "detailed interactions driving conformational changes seem different" (i.e. salt-bridge switches are not conserved).

In the text they note similarities to other ABC ATPases, and mention the signature helix, although they do not cite the recent NSMB or EMBO papers that experimentally dissected the role of residues on the signature helix (they rather cite a 2003 review). And in the Discussion they don\'t discuss whether or not a different set of salt bridge switches may coordinate conformational changes. To be fair this may be complicated by the low-resolution nature of the structure that would mean density for residues involved in salt bridges is poorly defined. So a detailed analysis without specific testing would be beyond the scope of this work. Yet, at a minimum, there should be at least some more specific discussion of this point with recent primary references that deal with a structural element that is key to the ATP-driven conformational change in the Rad50 ABC ATPase and likely in this similar ABC ATPase. This, unfortunately, is currently unclear from the manuscript.

2\) The authors\' response to point 7, asking if there are similarities in the effects of ATP binding to the MutS conformations seen in Hura et al., doesn\'t seem to make sense. They mention that in both cases it is the nucleotide that drives the change, yet then state that these observations don\'t correlate. "In this instance we are discussing the nucleotide and not MutL that drives the change whereas Hura et al. discuss the nucleotide rather than DNA driving the change. Hence this doesn\'t seem to correlate." However, because both experiments report on nucleotide-driven changes, they should correlate and be describable in terms of noted similarities and/or differences.

3\) The MutL N-terminal domain is also an ATPase. Is MutL also bound to nucleotide in their structure? This doesn\'t seem to be mentioned, and needs to be. It is mentioned that MutL can dimerize upon ATP binding and that the structure of the complex would sterically allow MutL dimerization based on a previously published structure of the N-terminal domain bound to nucleotide. However, this model is buried in [Figure 3--figure supplement 1F](#fig3s1){ref-type="fig"} and the ATP-binding region is not highlighted, which makes it hard to evaluate. Also, this model would suggest that the second MutL would be free to interact with an adjacent MutS dimer on DNA. While this is not seen as a stable complex in the reported gel filtration assays (only MutS-MutL heterotetramers are seen with DNA and AMPPNP), is there previously published evidence for this?

4\) In the subsection "Conformation of the MutS sliding clamp" they comment that "This type of ATP-induced tilting ... is more often observed upon ATP binding in ABC ATPases, such as ATP transporters, SMCs and RAD50". And then go on to say in a subsequent sentence that "the extent of the motion and the crossing of the DNA clamp domains of MutS was unexpected".

This is confusing as firstly it seems to imply that MutS is not an ABC ATPase when, in fact, it is. Also, it could be argued that this observation of subdomain rotations, while perhaps not predicted from earlier work on MutS, fits well with what is known from other ABC ATPases. Therefore, it is important as it bridges a previous gap in our understanding of MutS conformational changes versus other ABC ATPases. It furthermore facilitates future work to uncover a unified mechanism for how ATP drives conformational changes in ABC-ATPases. So a clearer and more unified discussion would be of considerable use to the MutS field but also to the entire ABC-ATPase superfamily. Perhaps they could provide some numbers giving the rotation angles in different systems, to quantify the size of motion they see here with respect to the other systems.

5\) They see that the mismatch binding domain becomes disordered in their structure, and propose that both this and the DNA may be present in the ∼35 Angstrom channel they observe. Some quantitation should be included here. Based on the structured volume of this domain and the volume that dsDNA would take up, is the space available in the channel that they see large enough for both the disordered mismatch recognition domain and DNA?

10.7554/eLife.06744.021

Author response

*1) According to section 7 of the submission guidelines, crystal structures must be deposited and the PDB validation reports must be provided to the referees. The referees should have a chance to examine these reports before the paper is accepted, and the PDB codes should be given in the text*.

The structures have PDB codes: 5AKB, 5AKC, 5AKD. A statement to this extent has been added to the text.

PDB validation reports are included with the revised version.

*2) In the Abstract, the statement about the structure being based on cysteine crosslinking could be misread as indicating that this was a hybrid structure based largely on inferred distances. It would be better to clarify in the Abstract that the desired conformation was trapped by cysteine crosslinking and that crosslinking experiments were also used to validate the molecular interactions inferred from the structure*.

Thanks for the comment; we have adjusted the Abstract to avoid this potential confusion.

*3) Several experiments are presented -- FRET, binding, crosslinking -- however, in most a control with non-mismatched DNA is missing. There are claims such as* "*dependent on mismatched DNA*" *that could not be made without these controls. Some of the FRET experiments should also be done with non-hydrolyzable ATP in addition to ATP. For the FRET experiments -- the data in supplementary material should include donor and acceptor curves, rather than just final FRET differences*.

This is a reasonable point. We have performed many of these controls in the past, but we have now added the references for those more explicitly when we make these statements e.g. to Winkler et al. (for crosslinking) and to Groothuizen et al. (for the SAXS experiments. We have added the requested homoduplex controls for the FRET experiments, [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}; we\'ve also added the raw data for these experiments in this figure.

The non-hydrolyzable ATP leads to a state that no longer loads onto DNA (as explained by our new state and discussed in the expanded Discussion). Therefore we have not added this control.

*4) The presentation is clear and concise, but it is disappointing that more of the paper was not devoted to describing the crystal structures plus their relationships to transient states, as together they answer many questions. For example, the packing within the crystal structure, as a potential filament on DNA, is of particular interest to many but left as supplement. An expanded discussion should address the transient states, the specificity and effect of MutL binding to MutS, and the new channel resulting from a novel conformation of MutS that reveals a rearrangement of the subunits in the MutS*^*ΔC800*^ *dimer*.

We have extended the Discussion to clarify how we see this structure in the context of the rich MutS literature.

With regard to the protein packing in the crystals, we think this is a crystallographic artefact as the observed packing could not occur in the presence of known MutL dimers. We have changed the text to reflect our ideas better.

*5) Importantly, this work establishes the ATP-bound conformation for MutS dimer with a greater motion than expected from prior MutS structures. In this novel MutS conformation the subunits are tilted across each other by ∼30{degree sign} which explains the stability of the MutS sliding clamp on DNA, compared to the mismatch recognition state. More detail on how this compares to the Rad50 ABC ATPAse ATP-bound conformation would be useful to readers, as the use of ABC ATPases in both mismatch and double-strand break repair has sparked considerable interest. E.g. the ABC ATPase signature helix identified from Rad50 conveys ATP-binding to Rad50 conformations, is this similar or different in the MutS changes in concert with ATP and MutL (Williams GJ et al., ABC ATPase signature helices in Rad50 link nucleotide state to Mre11 interface for DNA repair. Nat Struct Mol Biol. 2011 Apr;18(4):423-31)? Such conformational switching in Rad50 controls pathway progression and the choice between DNA end joining and excision, which may have parallels to these new MutS results or not (Deshpande RA et al., ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling. EMBO J. 2014 33, 482-500)*.

We have expanded the discussion on the similarities to other ABC ATPases such as RAD50 and the SMCs. The signature helix itself is indeed important (it contains the region identified by Mendillo et al that is buried by the connector domain) and the new position of the connector domain is overlapping with the position of the coiled coil regions in Rad50 in the AMP-PNP bound state.

However, the detailed interactions driving conformational changes seem different, as e.g. the switches identified by Williams et al., and the charge pairs that they observe as important are not conserved.

*6) The authors*\' *state that the* "*... sliding clamp state of MutS bound to a MutL domain is highly informative.*" *However their point that* "*it corresponds to a reaction intermediate that occurs during a series of conformational changes triggered by mismatch recognition*" *depends upon putting this work firmly into the context of existing results. Given the novel conformation of MutS and low-resolution coupled to issues from the heavy reliance on Cys mutants, cross-linked and truncated constructs and the absent electron density for the DNA, the authors would do well to better relate this work to other recent biophysical results where feasible, e.g. Gorman J, et al., Single-molecule imaging reveals target-search mechanisms during DNA mismatch repair. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3074-83 and DeRocco VC, Sass LE, Qiu R, Weninger KR, Erie DA. Dynamics of MutS-mismatched DNA complexes are predictive of their repair phenotypes. Biochemistry. 2014 Apr 1;53(12):2043-52*.

We have expanded the discussion of our work with the paper from Gorman as well as more detail how our work resolves conflicts in the smFRET results from Qiu et al. and Jeong et al.

However, the DeRocco paper focuses on differences between different mismatches before ATP addition. We showed previously in a quantitative SPR analysis that after ATP addition all off-rates are similar, despite differences in initial binding (Groothuizen et al. NAR 2014). Therefore we don\'t think these differences are relevant for the state observed here and therefore we have not discussed this particular paper.

*7) The authors also point out that their presented combination of structural and biophysical methods provides a powerful approach to resolve conformational changes within large and transient protein complexes. Thus, it would be useful to relate this model to recent data on the comprehensive conformational states for MutS and the model for bending then straightening steps in MutS damage recognition. X-ray scattering data was interpreted to suggest that nucleotide binding drives MutSβ conformational changes (Hura GL et al., Comprehensive macromolecular conformations mapped by quantitative SAXS analyses. Nat Methods. 2013 Jun;10(6):453-4.) These new observations would seem to be in general agreement with the SAXS results, e.g.* "*As this is measured in the absence of MutL it suggests that after mismatch binding, ATP is sufficient to induce movement of the connector domain away from the mismatch-recognition position*."

In this instance we are discussing the nucleotide and not MutL that drives the change whereas Hura et al. discuss the nucleotide rather than DNA driving the change. Hence this doesn\'t seem to correlate.

*8) For the crosslinked complex, the authors observe a two-step sequence of events, a first increase in FP simultaneous with an increase in FRET due to kinking of the DNA, then a second event increases FP even more but reduces the FRET signal to below starting value in which* "*... the DNA is not kinked any more but kept relatively rigid by the MutL*" *-- these data seem to support and extend results from X-ray scattering, which showed DNA bending then straightening upon formation of MutS/MutL complexes (Hura GL et al., DNA conformations in mismatch repair probed in solution by X-ray scattering from gold nanocrystals. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17308-13)*.

Indeed, good point; we\'ve added this reference.

*9) They do not observe the DNA in these structures. They claim that either the DNA is disordered (sliding along the channel that is formed) or that it was released. Could this be experimentally examined? Though not complete verification, were the crystals examined to see whether DNA was in the crystals? In one of the crystal forms the channels of at least 3 copies are aligned -- if the DNA is in there -- it might show fiber scattering along that axis. Do they see this? Would the DNA be able to stack along there (due to length)? Though they may not have a 2:2:1 complex anymore*.

The DNA would fit in our crystals in each case, but unfortunately we do not observe this. We\'ve carefully examined the diffraction patterns, but we really don\'t observe any fiber scattering in any of the three crystal forms. As stated in the text, it is possible that the sliding clamp diffuses away from the DNA. Alternatively it is still present, but in a disordered state for which we cannot observe any evidence. This type of weak interaction with DNA is in agreement with the single molecule studies that show that the sliding clamp no longer rotates on the DNA once it has made the clamp state ([@bib12]).

*10) In the Introduction, around the third paragraph, it would be good to help out the uninitiated reader by noting that the newly replicated strand is recognised by the lack of adenine methylation*.

We have adjusted the text to make this point.

*11) In the first paragraph of the Results, it would be good to mention the nature and length of the crosslinker. Until the clarification in subsection* "*MutS sliding clamp recognition by MutL*"*, it could appear that the authors were referring to disulphide bridge formation*.

We have adjusted the text to clarify this point early.

*12) In the second paragraph of the Results, the phrase* "*purification to obtain the protein in two successive cycles*" *should be clarified. Does this means that two purification steps were carried out*?

We have changed the text in order to make clear that we apply two full cycles of cross-linking and purification in order to fully cross-link the material and obtain sufficiently homogeneous material for crystallization.

*13) In the second paragraph of the subsection* "*MutS sliding clamp recognition by MutL*"*, it is not really appropriate to compare the 15.5Å distance between C-alpha atoms of Cys residues with the 18Å distance (really 17.8Å according to the Pierce information) between C atoms in the maleimide ring. In the cross-linked state, there will be three additional bonds on each side (CA-CB-SG-C), giving a significantly larger maximum distance between C-alpha atoms*.

As there may have been a lack of clarity in this section we\'ve rephrased it to state: 'Since the distance between Cα atoms of crosslinked residue 246C in MutS^ΔC800^ and residue 132 in MutL^LN40^ is ∼15.5 Å it is clear that an 18 Å crosslinker further spaced by the cysteine side-chains cannot enforce the observed position of the connector domain.'

*14) In the legend to* [*Figure 2--figure supplement 1*](#fig2s1){ref-type="fig"}*, there should be a capital* "*D*" *in the definition of the difference map coefficients, i.e.* "*mFo-DFc*"*. The authors should always indicate what types of electron density maps are presented (supplementary figures)*.

We\'ve made this change.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*1) In response to point 5 about how this new work related to the Rad50 ABC ATPase family member (specifically recent NSMB and EMBO papers), they mention that while* "*the signature helix itself is indeed important ... and the new position of the connector domain is overlapping with the position of the coiled coil regions in Rad50 in the AMP-PNP bound state*" *the* "*detailed interactions driving conformational changes seem different*" *(i.e. salt-bridge switches are not conserved)*.

*In the text they note similarities to other ABC ATPases, and mention the signature helix, although they do not cite the recent NSMB or EMBO papers that experimentally dissected the role of residues on the signature helix (they rather cite a 2003 review). And in the Discussion they don\'t discuss whether or not a different set of salt bridge switches may coordinate conformational changes. To be fair this may be complicated by the low-resolution nature of the structure that would mean density for residues involved in salt bridges is poorly defined. So a detailed analysis without specific testing would be beyond the scope of this work. Yet, at a minimum, there should be at least some more specific discussion of this point with recent primary references that deal with a structural element that is key to the ATP-driven conformational change in the Rad50 ABC ATPase and likely in this similar ABC ATPase. This, unfortunately, is currently unclear from the manuscript*.

Previously, we did not address this as MutS is different from RAD50 in this particular region. Hence this discussion will remain speculative, but we agree that it may be informative to be more specific about the differences between these ABC ATPase family members. Therefore we have added the following paragraph:

"In RAD50 this tilting or 'closing' motion is transmitted through a 'signature coupling helix' via charged interactions with the signature helix ([@bib14]; [@bib70]). This 'coupling helix' is found at the beginning of a long stretch (144-767) in Rad50 that includes the coiled coil region and ends in the signature helix. The equivalent region in MutS is only 10 residues long (660-669) and it is disordered in all structures. It is feasible that this 10-residue loop is critical for transmission of the ATP signal, but the details must be different, since the basic residues in the signature helix are not conserved in MutS."

*2) The authors\' response to point 7, asking if there are similarities in the effects of ATP binding to the MutS conformations seen in Hura et al., doesn\'t seem to make sense. They mention that in both cases it is the nucleotide that drives the change, yet then state that these observations don\'t correlate.* "*In this instance we are discussing the nucleotide and not MutL that drives the change whereas Hura et al. discuss the nucleotide rather than DNA driving the change. Hence this doesn\'t seem to correlate.*" *However, because both experiments report on nucleotide-driven changes, they should correlate and be describable in terms of noted similarities and/or differences*.

This is correct, and we\'ve added the Hura et al. reference to further support that ATP binding in the absence of DNA may be sufficient for the formation of a closed clamp state. However, the conformational changes of the connector domain most likely don\'t change the overall shape of ATP-bound MutS enough to be visible in SAXS analysis. In fact, the movements of the clamps and the mismatch-binding domains may well be uncoupled. This fits with [@bib65] who noted differences in FRET for the mismatch binding domain of ATP-bound MutS in the presence and absence of DNA. We are discussing this now as follows:

"These two movements could potentially be uncoupled. MutS binding to ATP can already cause a closed clamp-like state, (i.e. perform the tilting movement) as shown by SAXS analysis ([@bib33]), but may possibly not change the conformation of the mismatched binding domain ([@bib65]), as consequence of the connector domain movement. This would explain how MutS with ATPγS (or with ATP for a mutant that cannot hydrolyse nucleotides (E694A) ([@bib35])) could form a closed clamp state that can no longer be loaded onto DNA ([@bib13]; [@bib21]; [@bib35]), but nevertheless is not sufficient to bind MutL."

*3) The MutL N-terminal domain is also an ATPase. Is MutL also bound to nucleotide in their structure? This doesn\'t seem to be mentioned, and needs to be. It is mentioned that MutL can dimerize upon ATP binding and that the structure of the complex would sterically allow MutL dimerization based on a previously published structure of the N-terminal domain bound to nucleotide. However, this model is buried in* [*Figure 3--figure supplement 1F*](#fig3s1){ref-type="fig"} *and the ATP-binding region is not highlighted, which makes it hard to evaluate. Also, this model would suggest that the second MutL would be free to interact with an adjacent MutS dimer on DNA. While this is not seen as a stable complex in the reported gel filtration assays (only MutS-MutL heterotetramers are seen with DNA and AMPPNP), is there previously published evidence for this*?

Indeed, we did not make the nucleotide state of MutL explicit. We have added the following sentence to the text: "Accordingly the MutL monomers have the apo-conformation of residues 80-103 ([@bib8]) and no density for a nucleotide is visible."

To our knowledge, there is no published evidence for stable complex formation of MutS/MutL involving multiple dimers of both proteins forming ordered arrangements along DNA.

*4) In the subsection* "*Conformation of the MutS sliding clamp*" *they comment that* "*This type of ATP-induced tilting* ... *is more often observed upon ATP binding in ABC ATPases, such as ATP transporters, SMCs and RAD50*"*. And then go on to say in a subsequent sentence that* "*the extent of the motion and the crossing of the DNA clamp domains of MutS was unexpected*".

*This is confusing as firstly it seems to imply that MutS is not an ABC ATPase when, in fact, it is. Also, it could be argued that this observation of subdomain rotations, while perhaps not predicted from earlier work on MutS, fits well with what is known from other ABC ATPases. Therefore, it is important as it bridges a previous gap in our understanding of MutS conformational changes versus other ABC ATPases. It furthermore facilitates future work to uncover a unified mechanism for how ATP drives conformational changes in ABC-ATPases. So a clearer and more unified discussion would be of considerable use to the MutS field but also to the entire ABC-ATPase superfamily. Perhaps they could provide some numbers giving the rotation angles in different systems, to quantify the size of motion they see here with respect to the other systems*.

We\'ve changed the phrasing to be more clear that we do see the ABC tilt, but that the effects are more dramatic than we had foreseen. We\'ve changed the text to: "Based on comparison to RAD50 ([@bib31]) we previously predicted a tilting motion ([@bib45]), and an open-to-closed transition has been supported by deuterium exchange mass spectrometry ([@bib56]), but the crossing of the clamp domains of MutS and the effect that this has on DNA binding were unexpected."

*5) They see that the mismatch binding domain becomes disordered in their structure, and propose that both this and the DNA may be present in the ∼35 Angstrom channel they observe. Some quantitation should be included here. Based on the structured volume of this domain and the volume that dsDNA would take up, is the space available in the channel that they see large enough for both the disordered mismatch recognition domain and DNA*?

In our crystal structure both connector domains move away and interact with MutL, and hence the N-terminal mismatch recognition domains both move away from the channel. However the channel is indeed rather wide and we speculate that this complete movement may not be necessary in an asymmetric situation. That said, small adjustments could be necessary to accommodate possible clashes. In the absence of visible DNA there seem to be too many possibilities to model these potential states.

[^1]: Highest resolution shell is shown in parenthesis.

[^2]: Mutation rates and 95% confidence intervals were determined using the Fluctuation AnaLysis CalculatOR (<http://www.mitochondria.org/protocols/FALCOR.html>) using the MSS-MLE method. For MutS, at least 24 independent colonies were picked; for MutL at least 12 independent colonies were picked.
